Treatment failure in patients with chronic Blastocystis infection

Journal of Medical Microbiology

Volumn 63, Issue PART 2, 2014, Pages 252-257

  Roberts, Tamalee ^a,b   Ellis, John ^b   Harkness, John ^a   Marriott, Deborah ^a   Stark, Damien ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DIIODOHYDROXYQUIN; DOXYCYCLINE; FURAZOLIDONE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; RIBOSOME DNA; SECNIDAZOLE; TINIDAZOLE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BLASTOCYSTIS; BLASTOCYSTOSIS; BLOATING; CHILD; CLINICAL ARTICLE; DIARRHEA; DIENTAMOEBA; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENTAMOEBA DISPAR; FECES; FECES CULTURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; NAUSEA; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VOMITING; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; CHILD; CHRONIC DISEASE; COHORT STUDIES; DNA, PROTOZOAN; DRUG THERAPY, COMBINATION; FECES; FEMALE; FURAZOLIDONE; GENOTYPE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; THIAZOLES; TREATMENT FAILURE; YOUNG ADULT;

EID: 84892993391     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.065508-0     Document Type: Article

References (39)

1. Andiran, N., Acikgoz, Z. C., Turkay, S. & Andiran, F. (2006). Blastocystis hominis - an emerging and imitating cause of acute abdomen in children. J Pediatr Surg 41, 1489-1491.
2. Armentia, A., Mèndez, J., Gómez, A., Sanchís, E., Fernández, A., de la Fuente, R. & Sánchez, P. (1993). Urticaria by Blastocystis hominis. Successful treatment with paromomycin. Allergol Immunopathol (Madr) 21, 149-151.
3. Boorom, K. F., Smith, H., Nimri, L., Viscogliosi, E., Spanakos, G., Parkar, U., Li, L.H., Zhou, X.N., Ok, Ã. Z. & other authors (2008). Ohmy aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasite Vectors 1, 40.
4. Cimerman, S., Ladeira, M. C. & Iuliano, W. A. (2003). Blastocystosis: nitazoxanide as a new therapeutic option. Rev Soc Bras Med Trop 36, 415-417 (in Portuguese).
5. Dinleyici, E. C., Eren, M., Dogan, N., Reyhanioglu, S., Yargic, Z. A. & Vandenplas, Y. (2011). Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 108, 541-545.
6. Forsell, J., Granlund, M., Stensvold, C. R., Clark, G. C. & Evengård, B. (2012). Subtype analysis of Blastocystis isolates in Swedish patients. Eur J Clin Microbiol Infect Dis 31, 1689-1696.
7. Fotedar, R., Stark, D., Beebe, N., Marriott, D., Ellis, J. & Harkness, J. (2007). PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol 45, 1035-1037.
8. Hussein, E. M., Hussein, A. M., Eida, M. M. & Atwa, M. M. (2008). Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 102, 853-860.
9. Jantermtor, S., Pinlaor, P., Sawadpanich, K., Pinlaor, S., Sangka, A., Wilailuckana, C., Wongsena, W. & Yoshikawa, H. (2013). Subtype identification of Blastocystis spp. isolated from patients in a major hospital in northeastern Thailand. Parasitol Res 112, 1781-1786.
10. Jones, M. S., Whipps, C. M., Ganac, R. D., Hudson, N. R. & Boorom, K. (2009). Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res 104, 341-345.
11. Kick, G., Rueff, F. & Przybilla, B. (2002). Palmoplantar pruritus subsiding after Blastocystis hominis eradication. Acta Derm Venereol 82, 60.
12. Leelayoova, S., Rangsin, R., Taamasri, P., Naaglor, T., Thathaisong, U. & Mungthin, M. (2004). Evidence of waterborne transmission of Blastocystis hominis. Am J Trop Med Hyg 70, 658-662.
13. Markell, E. K. & Udkow, M. P. (1986). Blastocystis hominis: pathogen or fellow traveler? Am J Trop Med Hyg 35, 1023-1026.
14. Meenagh, A., Williams, F., Ross, O. A., Patterson, C., Gorodezky, C., Hammond, M., Leheny, W. A. & Middleton, D. (2002). Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 63, 1055-1061.
15. Meloni, D., Sanciu, G., Poirier, P., El Alaoui, H., Chabè, M., Delhaes, L., Dei-Cas, E., Delbac, F., Luigi Fiori, P. & other authors (2011). Molecular subtyping of Blastocystis spp. isolates from symptomatic patients in Italy. Parasitol Res 109, 613-619.
16. Mirza, H., Teo, J. D., Upcroft, J. & Tan, K. S. (2011). A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 55, 637-648.
17. Moghaddam, D. D., Ghadirian, E. & Azami, M. (2005). Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res 96, 273-275.
18. Nagel, R., Cuttell, L., Stensvold, C. R., Mills, P. C., Bielefeldt-Ohmann, H. & Traub, R. J. (2012). Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J 42, 1187-1195.
19. Nigro, L., Larocca, L., Massarelli, L., Patamia, I., Minniti, S., Palermo, F. & Cacopardo, B. (2003). A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 10, 128-130.
20. Ok, U. Z., Girginkardeşler, N., Balcioǧlu, C., Ertan, P., Pirildar, T. & Kilimcioǧlu, A. A. (1999). Effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection. Am J Gastroenterol 94, 3245-3247.
21. Olivo-Diaz, A., Romero-Valdovinos, M., Gudiño-Ramirez, A., Reyes-Gordillo, J., Jimenez-Gonzalez, D. E., Ramirez-Miranda, M. E., Martinez-Flores, W. A., Martinez-Hernandez, F., Flisser, A. & Maravilla, P. (2012). Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol Res 111, 487-491.
22. Ozyurt, M., Kurt, O., Mølbak, K., Nielsen, H. V., Haznedaroglu, T. & Stensvold, C. R. (2008). Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int 57, 300-306.
23. Parkar, U., Traub, R. J., Vitali, S., Elliot, A., Levecke, B., Robertson, I., Geurden, T., Steele, J., Drake, B. & Thompson, R. C. (2010). Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. Vet Parasitol 169, 8-17.
24. Pasqui, A. L., Savini, E., Saletti, M., Guzzo, C., Puccetti, L. & Auteri, A. (2004). Chronic urticaria and Blastocystis hominis infection: a case report. Eur Rev Med Pharmacol Sci 8, 117-120.
25. Pipatsatitpong, D., Rangsin, R., Leelayoova, S., Naaglor, T. & Mungthin, M. (2012). Incidence and risk factors of Blastocystis infection in an orphanage in Bangkok, Thailand. Parasite Vectors 5, 37.
26. Roberts, T., Stark, D., Harkness, J. & Ellis, J. (2013). Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis. Eur J Clin Microbiol Infect Dis 32, 335-343.
27. Romero Cabello, R., Guerrero, L. R., Muñóz García, M. R. & Geyne Cruz, A. (1997). Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 91, 701-703.
28. Rossignol, J. F., Kabil, S. M., Said, M., Samir, H. & Younis, A. M. (2005). Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 3, 987-991.
29. Stark, D., van Hal, S., Marriott, D., Ellis, J. & Harkness, J. (2007). Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 37, 11-20.
30. Stark, D., Barratt, J., Roberts, T., Marriott, D., Harkness, J. & Ellis, J. (2010). Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. Eur J Clin Microbiol Infect Dis 29, 411-416.
31. Stensvold, C. R., Arendrup, M. C., Jespersgaard, C., Mølbak, K. & Nielsen, H. V. (2007). Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis 59, 303-307.
32. Stensvold, C. R., Arendrup, M. C., Nielsen, H. V., Bada, A. & Thorsen, S. (2008). Symptomatic infection with Blastocystis spp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole. Ann Trop Med Parasitol 102, 271-274.
33. Stensvold, C. R., Lewis, H. C., Hammerum, A. M., Porsbo, L. J., Nielsen, S. S., Olsen, K. E., Arendrup, M. C., Nielsen, H. V. & Mølbak, K. (2009). Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 137, 1655-1663.
34. Stensvold, C. R., Smith, H. V., Nagel, R., Olsen, K. E. & Traub, R. J. (2010). Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 44, 85-90.
35. Tan, K. S. (2008). New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21, 639-665.
36. Tan, K. S., Singh, M. & Yap, E. H. (2002). Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol 32, 789-804.
37. Valsecchi, R., Leghissa, P. & Greco, V. (2004). Cutaneous lesions in Blastocystis hominis infection. Acta Derm Venereol 84, 322-323.
38. van Hellemond, J. J., Molhoek, N., Koelewijn, R., Wismans, P. J. & van Genderen, P. J. (2013). Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother 19, 545-548.
39. Vogelberg, C., Stensvold, C. R., Monecke, S., Ditzen, A., Stopsack, K., Heinrich-Gräfe, U. & Pöhlmann, C. (2010). Blastocystis spp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int 59, 469-471.